BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27785332)

  • 21. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
    Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
    Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.
    Ichikawa A; Arakawa F; Kiyasu J; Sato K; Miyoshi H; Niino D; Kimura Y; Takeuchi M; Yoshida M; Ishibashi Y; Nakashima S; Sugita Y; Miura O; Ohshima K
    Eur J Haematol; 2013 Jul; 91(1):20-8. PubMed ID: 23560463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synchronous Microscopic Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma of the Adrenal and Lymphoplasmacytic Lymphoma: De Novo Disease or Transformation?
    Moonim MT; Nasir A; Hubbard J; Ketley N; Fields P
    Int J Surg Pathol; 2017 Jun; 25(4):326-332. PubMed ID: 27913781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of Epstein-Barr virus-associated primary vitreoretinal lymphoma in an immunosuppressed patient.
    Sun C; Muraoka Y; Ishihara K; Morooka S; Akada M; Hata M; Tsujikawa A
    Retin Cases Brief Rep; 2023 Sep; ():. PubMed ID: 37769245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevalence and clinico-pathological characteristics in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma in a high complexity hospital in Cali, Columbia].
    Amaya D; Moreno JC; Calvache N; Castro A; Pérez B; Silva N
    Rev Esp Patol; 2019; 52(3):139-146. PubMed ID: 31213254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Epstein-Barr virus-related lymphomas in patients with inflammatory bowel disease].
    Juffermans NP; Jager A; Kersten MJ; van Oers MH; Hommes DW
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1859-63. PubMed ID: 16128185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus-positive oral ulceration simulating Hodgkin lymphoma in a patient treated with methotrexate: case report and review of the literature.
    Naidu A; Kessler HP; Pavelka MA
    J Oral Maxillofac Surg; 2014 Apr; 72(4):724-9. PubMed ID: 24246254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus-positive diffuse large B-cell lymphoma association is not only restricted to elderly patients.
    Cohen M; Narbaitz M; Metrebian F; De Matteo E; Preciado MV; Chabay PA
    Int J Cancer; 2014 Dec; 135(12):2816-24. PubMed ID: 24789501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refractory inflammatory bowel disease: is there a role for Epstein-Barr virus? A case-controlled study using highly sensitive Epstein-Barr virus-encoded small RNA1 in situ hybridization.
    Pezhouh MK; Miller JA; Sharma R; Borzik D; Eze O; Waters K; Westerhoff MA; Parian AM; Lazarev MG; Voltaggio L
    Hum Pathol; 2018 Dec; 82():187-192. PubMed ID: 30120969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells.
    Ohashi A; Kato S; Okamoto A; Inaguma Y; Satou A; Tsuzuki T; Emi N; Okamoto M; Nakamura S
    Histopathology; 2017 Jul; 71(1):89-97. PubMed ID: 28231401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma.
    Beltran BE; Quiñones P; Morales D; Malaga JM; Chavez JC; Sotomayor EM; Castillo JJ
    Hematol Oncol; 2018 Feb; 36(1):93-97. PubMed ID: 28639256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphoproliferative disorder with pathological fracture of the femur in a patient with rheumatoid arthritis treated with methotrexate: A case report.
    Oebisu N; Hoshi M; Ieguchi M; Iwai T; Tanaka S; Osawa M; Nakamura H
    Mol Clin Oncol; 2018 Aug; 9(2):187-191. PubMed ID: 30101019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
    Morishima S; Nakamura S; Yamamoto K; Miyauchi H; Kagami Y; Kinoshita T; Onoda H; Yatabe Y; Ito M; Miyamura K; Nagai H; Moritani S; Sugiura I; Tsushita K; Mihara H; Ohbayashi K; Iba S; Emi N; Okamoto M; Iwata S; Kimura H; Kuzushima K; Morishima Y
    Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection.
    Miyazaki T; Fujimaki K; Shirasugi Y; Yoshiba F; Ohsaka M; Miyazaki K; Yamazaki E; Sakai R; Tamaru J; Kishi K; Kanamori H; Higashihara M; Hotta T; Ishigatsubo Y
    Am J Hematol; 2007 Dec; 82(12):1106-9. PubMed ID: 17654684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis.
    Maruani A; Wierzbicka E; Machet MC; Abdallah-Lotf M; de Muret A; Machet L
    J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S69-71. PubMed ID: 17938029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection.
    Lioté F; Pertuiset E; Cochand-Priollet B; D'Agay MF; Dombret H; Numéric P; D'Anglejan G; Kuntz D
    J Rheumatol; 1995 Jun; 22(6):1174-8. PubMed ID: 7674250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Epstein-Barr virus-positive diffuse large B-cell lymphoma presenting as multi-organ failure: a catastrophic lymphomatosis with fulminant visceral organ dissemination resulting in a precipitous death in a 59-year-old female with no identifiable etiology for immunodeficiency.
    Wang E; Papavassiliou P; Wei Q; Wickham MQ; Cichon L; Proia AD
    Pathol Res Pract; 2014 Jan; 210(1):62-6. PubMed ID: 24120731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein--Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin.
    Verma S; Frambach GE; Seilstad KH; Nuovo G; Porcu P; Magro CM
    J Cutan Pathol; 2005 Aug; 32(7):474-83. PubMed ID: 16008691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The presence of Epstein-Barr virus (EBV) in diffuse large B-cell lymphomas (DLBCLs) in Turkey: special emphasis on 'EBV-positive DLBCL of the elderly'.
    Uner A; Akyurek N; Saglam A; Abdullazade S; Uzum N; Onder S; Barista I; Benekli M
    APMIS; 2011 Apr; 119(4-5):309-16. PubMed ID: 21492232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes among North American patients with diffuse large B-cell lymphoma are independent of tumor Epstein-Barr virus positivity or immunosuppression.
    Tracy SI; Habermann TM; Feldman AL; Maurer MJ; Dogan A; Perepu US; Syrbu S; Ansell SM; Thompson CA; Weiner GJ; Nowakowski GS; Allmer C; Slager SL; Witzig TE; Cerhan JR; Link BK
    Haematologica; 2018 Feb; 103(2):297-303. PubMed ID: 29170255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.